Christine M. Nucker

Array ( [id] => 3788835 [patent_doc_number] => 05736626 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Solid support reagents for the direct synthesis of 3\'-labeled polynucleotides' [patent_app_type] => 1 [patent_app_number] => 8/593031 [patent_app_country] => US [patent_app_date] => 1996-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9361 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736626.pdf [firstpage_image] =>[orig_patent_app_number] => 593031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3764862 [patent_doc_number] => 05733549 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Peptides including amino acid sequences selected from lipoprotein (a) and apolipoprotein (a), antibodies recognizing these amino acid sequences, and methods of determination using these antibodies' [patent_app_type] => 1 [patent_app_number] => 8/211747 [patent_app_country] => US [patent_app_date] => 1994-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 36 [patent_no_of_words] => 32516 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733549.pdf [firstpage_image] =>[orig_patent_app_number] => 211747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790529 [patent_doc_number] => 05726011 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Method for diagnosing chronic hepatitis B virus infection' [patent_app_type] => 1 [patent_app_number] => 8/221098 [patent_app_country] => US [patent_app_date] => 1994-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 7632 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726011.pdf [firstpage_image] =>[orig_patent_app_number] => 221098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3589498 [patent_doc_number] => 05585351 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-12-17 [patent_title] => 'T-cadherin adhesion molecule' [patent_app_type] => 1 [patent_app_number] => 8/213361 [patent_app_country] => US [patent_app_date] => 1994-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 23 [patent_no_of_words] => 6646 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/585/05585351.pdf [firstpage_image] =>[orig_patent_app_number] => 213361 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3609726 [patent_doc_number] => 05534257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-07-09 [patent_title] => 'Antigen-presenting capsid with fusion MS2-coat protein' [patent_app_type] => 1 [patent_app_number] => 8/090148 [patent_app_country] => US [patent_app_date] => 1993-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6280 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/534/05534257.pdf [firstpage_image] =>[orig_patent_app_number] => 090148 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3683044 [patent_doc_number] => 05690938 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-25 [patent_title] => 'Oral immunization with multiple particulate antigen delivery system' [patent_app_type] => 1 [patent_app_number] => 8/131630 [patent_app_country] => US [patent_app_date] => 1993-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 24 [patent_no_of_words] => 10747 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/690/05690938.pdf [firstpage_image] =>[orig_patent_app_number] => 131630 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689398 [patent_doc_number] => 05679348 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Immunotherapy for recurrent HSV infections' [patent_app_type] => 1 [patent_app_number] => 7/829947 [patent_app_country] => US [patent_app_date] => 1992-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 9600 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679348.pdf [firstpage_image] =>[orig_patent_app_number] => 829947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3458410 [patent_doc_number] => 05401829 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-03-28 [patent_title] => 'Biologically active molecules' [patent_app_type] => 1 [patent_app_number] => 7/813110 [patent_app_country] => US [patent_app_date] => 1991-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5929 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/401/05401829.pdf [firstpage_image] =>[orig_patent_app_number] => 813110 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3469950 [patent_doc_number] => 05476658 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1995-12-19 [patent_title] => 'Vaccine against hepatitis a comprising simian HAV isolate AGM-27' [patent_app_type] => 1 [patent_app_number] => 7/674852 [patent_app_country] => US [patent_app_date] => 1991-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 4161 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/476/05476658.pdf [firstpage_image] =>[orig_patent_app_number] => 674852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2859840 [patent_doc_number] => 05082768 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-01-21 [patent_title] => 'Attenuator to suppress extraneous light in luminescent specific-binding assays' [patent_app_type] => 1 [patent_app_number] => 7/639302 [patent_app_country] => US [patent_app_date] => 1990-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 8 [patent_no_of_words] => 7375 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/082/05082768.pdf [firstpage_image] =>[orig_patent_app_number] => 639302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2708889 [patent_doc_number] => 05013831 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-05-07 [patent_title] => 'Detectable molecules, method of preparation and use' [patent_app_type] => 1 [patent_app_number] => 7/521762 [patent_app_country] => US [patent_app_date] => 1990-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14629 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 269 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/013/05013831.pdf [firstpage_image] =>[orig_patent_app_number] => 521762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2743193 [patent_doc_number] => 05002885 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-03-26 [patent_title] => 'Detectable molecules, method preparation and use' [patent_app_type] => 1 [patent_app_number] => 7/513723 [patent_app_country] => US [patent_app_date] => 1990-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14706 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 182 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/002/05002885.pdf [firstpage_image] =>[orig_patent_app_number] => 513723 [rel_patent_id] =>[rel_patent_doc_number] =>)